ISTH 2020 Congress

Fibrinolysis and Proteolysis » Fibrinogen and Factor XIII

Theme Navigation

ISTH 2020 Congress
- Fibrinolysis and Proteolysis
  - Fibrinogen and Factor XIII

Abstract Number: PB0711

A Case Report of Spontaneous and Recurrent Arterial and Venous Thrombotic Events in a Child with FGA c.1372C>T Mutation

H. Yixuan, W. Runhui, Z. Rui, Y. Jiafeng

Abstract Number: PB0732

A Genetic Modifier of Venous Thrombosis in Zebrafish Reveals a Functional Role for Fibrinogen AαE in Early Hemostasis

R.J. Fish¹, C. Freire¹, R. Vilar², C. Di Sanza¹, S.J. Grzegorski³, C.E. Richter⁴, J.A. Shavit³, M. Neerman-Arbez¹

Abstract Number: PB0735

A New Genetic Alteration in Fibrinogen Gene with a Direful Phenotype: A Tie-in in a Newborn

T. Nafees, Bleeding Disorder Working Group

Abstract Number: PB0712

Assessment of in vitro Effects of Direct Thrombin Inhibitors on Activation of Coagulation Factor XIII through Enzyme Kinetics in the Synthetic Substrate-Based Assay

Y. Fujimori¹, M. Wakui², S. Nakamura³, Y. Kondo³, Y. Ozaki³, S. Oka³, T. Nakagawa³, H. Katagiri³, M. Murata²

Abstract Number: PB0722

Cellular Factor XIII Externalization in Platelets and Platelet Microparticles Induced by Receptor Mediated and Non-Receptor Mediated Platelet Activation

L. Somodi¹, I. Beke Debreceni², H. Bárdos³, Á. Bana³, J. Kappelmayer², L. Muszbek¹

Abstract Number: OC 02.2

Chemical Modulation of Fibrinogen Production and its Impact on Venous Thrombosis

R. Vilar¹, S.W. Lukowski², M. Garieri¹, C. Di Sanza¹, M. Neerman-Arbez^1,3, R.J. Fish¹

Abstract Number: PB0725

Comparison Natural History and Genotype of 31 Patients with Inherited Dysfibrinogenemia

T. Simurda¹, J. Zolkova¹, I. Skornova¹, M. Brunclikova¹, Z. Kolkova², D. Loderer², M. Dobrotova¹, J. Ivankova¹, M. Grendar², Z. Lasabova³, J. Stasko¹, P. Kubisz¹

Abstract Number: PB0719

Congenital Qualitative Fibrinogen Disorders: Case Series from Argentina; Multicentric Collaborative Study

C.M. Rosa¹, M. Neerman-Arbez², C. Duboscq³, A. Vilaseca⁴, J. Ceresetto³, M.E. Aris Cancela⁵, P. Colimodio⁵, L. Barrera^6,7, M.S. Lopez^6,7, J.M. Oyhamburu^6,7, V. Privitera⁸, E.S. Viñuales⁸, E. Nucifora⁸, M. Kalmus⁸, S. Meschengieser⁹, A. Casini¹⁰, P. de Moerloose¹¹, M.E. Martinuzzo^7,12

Abstract Number: PB0716

Effects of Lysine-Containing Peptides Treatment on FXIII Activity and Fibrinogen Level of Metabolic Disorders

T. Shubina, T. Obergan

Abstract Number: PB0730

Eight Succesfull Pregnancies in Patients with Congenital Fibrinogen Disorders – Single Centre Study

V. Pohlreichová, I. Čapová, V. Geierová, J. Loužil, E. Ceznerová, R. Kotlín, I. Hrachovinová, P. Salaj

Abstract Number: PB0726

Factor XIII Cross-Links Fibrin(ogen) Independent of Fibrin Polymerization in Experimental Acute Liver Injury

L.G. Poole^1,2, A.K. Kopec¹, D.J. Groeneveld¹, A. Pant¹, K.S. Baker^2,3, H.M. Cline-Fedewa¹, M.J. Flick⁴, J.P. Luyendyk^1,2,3

Abstract Number: PB0731

Factor XIII-A Is Present within Organelles Known to Mediate Unconventional Protein Secretion

P. Cordell¹, R. Pease²

Abstract Number: PB0715

Factor XIIIa-Mediated Red Blood Cell Retention in the Contracting Clot Is Impaired in Hereditary Dysfibrinogenemia

R. Marchi^1,2, F. Macrae³, M. Neerman-Arbez⁴, P. Fontana², R. Ariëns³, A. Casini²

Abstract Number: PB0721

Fibrin Deposition in Mouse Transfusion-Related Acute Lung Injury Via Coagulation or Fibrinolysis Dysfunction

Y. Yu, P. Jiang, P. Sun, N. Su, X. Yuan, F. Lin

Abstract Number: OC 02.1

Fibrin γ-chain Crosslinking Plays an Important Role in Preventing Thrombus Breakdown and Embolisation in-vivo

C. Duval¹, A. Baranauskas¹, M. Ali¹, Z. Raslan¹, S.R. Baker¹, H.R. McPherson¹, M.A. Bailey¹, R.M. Cubbon¹, R.A. Ajjan¹, H. Philippou¹, K.K. Naseem¹, V.C. Ridger², R.A.S. Ariëns¹

Abstract Number: PB0713

Fibrinogen Concentrate Replacement Guided by Thromboelastometry Can Improve Clot Strenght in Adult Dengue with Severe Thrombocytopenia

T. Crochemore¹, F. Savioli²

Abstract Number: OC 02.4

High Individual Variation of Thrombin Generation by Genesia and Correlation of Fibrin-Associated ROTEM with Fibrinogen Activity in Patients with Congenital Fibrinogen Defects

T. Szanto¹, R. Lassila², M. Lemponen³, E. Lehtinen³, M. Neerman-Arbez⁴, A. Casini⁵

« View all themes from the ISTH 2020 Congress